Iyo Spike glycoprotein receptor-binding domain (RBD) yeSARS-CoV-2 inopindirana nehutachiona hwehutachiona hunosunga kune angiotensin-inoshandura enzyme 2 (ACE2) receptor pamusoro pemasero emunhu.Naizvozvo, kudyidzana kweSpike-ACE2 chinhu chakakosha chinotaridza hutachiona hwehutachiona.A new phylogenetic group yeSARS-CoV-2 (mutsara B.1.1.7), iyo ine amino acid inotsiva muSpike RBD (N501Y mutation).
Zvinoenderana netsvagiridzo nyowani kubva kuDhipatimendi rehutano reUK, zvichibva pane data rese genome sequencing, epidemiology uye modhi, kutapukira kwekusiyana kweSARS-CoV-2 kunoda kusvika 40-70% yakakwirira kupfuura imwe sainzi inowanika ino zivikanwa. .Kupindura nekukurumidza uye kuona ndeimwe yenzira yakakosha yekudzivirira nekudzora chiyero.
Iyo kit inoshandiswa kune in vitro qualitative yekuona iyo ORF1ab/N/S genes yenovel coronavirus 2019-nCoV mumhando dzekufema, uye kuita mutation typing paN501Y panguva imwe chete.
Iyo kit inotora nzira yeARMS, inotora iyo S gene ye novel coronavirus (2019-nCoV) senzvimbo yakanangwa yekuchinja kutaipa, inogadzira iyo chaiyo primers uye probes yeN501Y.
| Products | Specs | Store temp | Tsanangudzo |
| Real Time PCR Kit yeNovelCoronavirus 2019-nCoV uyeNovel Coronavirus 2019-nCoVGene Mutation (N501Y) | 48T | -20 ℃ | Vaongorori: Wild-mhando yeN501Y,Mutant mhando yeN501Y, ORF1ab,N gene uye Internal control |
Template Compatibility
- Oropharyngeal Swabs
- Nasopharyngeal Swab
- Bronchoalveolar Lavage Fluid
- Sputum
Kit Zvikamu
- RT-PCR reaction buffer
- RT-PCR enzyme musanganiswa
- Wild-type positive control
- Mutated positive control
- Negative control
N501Y Mutation Type
